FOR LABORATORY RESEARCH USE ONLY

Not for human or veterinary consumption, administration, diagnosis, treatment, or other clinical use. Website information is not medical advice.

READ RESEARCH USE POLICY

AGR // RESEARCH PRODUCT DOSSIER

AGR-MTC1

MOTS-C

Technical information, documentation status, qualification tracking, and independent peer-reviewed literature are presented in separate sections below.

QUALIFICATION STATUSDOCUMENTATION REVIEW
MOTS-C AGR concept vial CONCEPT PRESENTATION // NOT QUALIFIED INVENTORY

PRODUCT OVERVIEW

Research material profile

← ALL PRODUCTS
PRODUCT CODEAGR-MTC1
CLASSIFICATIONMitochondrial-derived peptide research material
MOLECULAR FORMULAC₁₀₁H₁₅₂N₂₈O₂₂S₂
MOLECULAR WEIGHT≈ 2,174.6 g/mol
CAS NUMBER1627580-64-6
APPEARANCELyophilized research material
PACKAGING CONCEPT10 mg concept configuration
RESEARCH THEMES
  • Mitochondrial signaling
  • AMPK-associated pathways
  • Cellular energy research
TECHNICAL INFORMATION BOUNDARY

This dossier intentionally contains no dosing, reconstitution, administration, injection, or human-use instructions. Molecular and packaging information is descriptive only.

PRODUCT DOCUMENTATION

Documentation Center

COA AVAILABLE
THIRD-PARTY LABORATORY DOCUMENTATIONAVAILABLE

MOTS-C 10 mg Certificate of Analysis

Batch-specific UPLC/MS certificate issued for Alpha Guardian Research. Open the complete laboratory report for chromatograms, mass spectrometry data, and validation details.

Laboratory
Purple Research Labs
Batch / Lot
AG-9952500-G
Measured quantity
10.21 mg
Reported purity
99.24%
AGR THIRD-PARTY LABORATORY DOCUMENTATIONPENDING

Third-Party Laboratory Reports

AGR results will remain clearly separated from manufacturer documentation.

  • Identity confirmationPENDING
  • Purity analysisPENDING
  • EndotoxinPENDING
  • SterilityPENDING
  • Heavy metalsPENDING
SUPPORTING RECORDSPENDING

Additional Documentation

  • Safety Data SheetPending source review
  • Qualification summaryPending
  • Chain-of-custody recordPending testing
  • Batch historyNo assigned batch

QUALIFICATION STATUS

Evidence trail

VIEW FULL FRAMEWORK →
01Third-Party TestingCOMPLETE
02Documentation ReviewCOMPLETE
03AGR Quality ReviewPENDING
04AGR Documentation ReviewedNOT QUALIFIED
QUALIFICATION NOTES

No supplier, batch, or inventory is represented as AGR Documentation Reviewed on this page. Status changes must be supported by the corresponding documentation.

LITERATURE SNAPSHOT

Current AGR index

SEARCH ALL LITERATURE →
3CURATED PUBLICATIONS
4HUMAN-FOCUSED RECORDS*
2023EARLIEST INDEXED YEAR
2024LATEST INDEXED YEAR

*Based on study descriptions currently indexed by AGR. This snapshot is not a complete count of all published literature and is independent of product qualification.

INDEPENDENT SCIENTIFIC LITERATURE

Peer-reviewed publications

OPEN LITERATURE DATABASE →
SEPARATE FROM PRODUCT DOCUMENTATION

The publications below concern the compound as studied by independent researchers. They do not verify the identity, purity, safety, or performance of any AGR product.

MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation

Open-access review · Zheng et al.
PUBLICATION RECORD

Independent peer-reviewed publication. AGR does not summarize this record as evidence of product safety, efficacy, clinical suitability, or intended use. Review the linked source for the authors’ findings.

SCOPE NOTICE

This publication concerns the compound or research topic studied by its authors and does not verify any AGR material or establish an approved or recommended use.

READ STUDY ON PUBMED / SOURCE ↗

The correlation between mitochondrial-derived peptide MOTS-c and obesity and diabetes

Peer-reviewed meta-analysis · Zhou et al.
PUBLICATION RECORD

Independent peer-reviewed publication. AGR does not summarize this record as evidence of product safety, efficacy, clinical suitability, or intended use. Review the linked source for the authors’ findings.

SCOPE NOTICE

This publication concerns the compound or research topic studied by its authors and does not verify any AGR material or establish an approved or recommended use.

READ STUDY ON PUBMED / SOURCE ↗

Mitochondrial-derived peptides in cardiovascular disease

Cardiovascular research review · Li et al.
PUBLICATION RECORD

Independent peer-reviewed publication. AGR does not summarize this record as evidence of product safety, efficacy, clinical suitability, or intended use. Review the linked source for the authors’ findings.

SCOPE NOTICE

This publication concerns the compound or research topic studied by its authors and does not verify any AGR material or establish an approved or recommended use.

READ STUDY ON PUBMED / SOURCE ↗
AGR RESEARCH INTEGRITY

Summaries are educational and do not replace the full paper. Evidence labels describe study design, not product quality, regulatory approval, or expected outcomes.